|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 6135 for Fas

<< First    < Previous  |  Next >    Last >>
0.039s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chimpanzee
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Gene
Type: gene
Organism: human
Publication
First Author: Chervonsky AV
Year: 1997
Journal: Cell
Title: The role of Fas in autoimmune diabetes.
Volume: 89
Issue: 1
Pages: 17-24
Publication
First Author: Mandik L
Year: 1995
Journal: Eur J Immunol
Title: Fas receptor expression on B-lineage cells.
Volume: 25
Issue: 11
Pages: 3148-54
Publication
First Author: Schneider TJ
Year: 1999
Journal: J Exp Med
Title: A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes.
Volume: 189
Issue: 6
Pages: 949-56
Publication
First Author: Cui H
Year: 1996
Journal: Cell Immunol
Title: Functional expression of Fas (CD95) protein in autoimmune lpr mice.
Volume: 174
Issue: 1
Pages: 35-41
Publication
First Author: Song J
Year: 2000
Journal: J Clin Invest
Title: Roles of Fas and Fas ligand during mammary gland remodeling.
Volume: 106
Issue: 10
Pages: 1209-20
Publication
First Author: Gujral JS
Year: 2004
Journal: Hepatology
Title: Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.
Volume: 40
Issue: 4
Pages: 998-1007
Publication
First Author: Kim S
Year: 2000
Journal: J Immunol
Title: Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Volume: 164
Issue: 6
Pages: 2931-6
Publication
First Author: Xu JP
Year: 1998
Journal: Zygote
Title: Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-lpr/lpr murine ovary.
Volume: 6
Issue: 4
Pages: 359-67
Publication
First Author: Sharov AA
Year: 2004
Journal: Cancer Res
Title: Fas signaling is involved in the control of hair follicle response to chemotherapy.
Volume: 64
Issue: 17
Pages: 6266-70
Publication
First Author: Nagata S
Year: 1994
Journal: Semin Immunol
Title: Mutations in the Fas antigen gene in lpr mice.
Volume: 6
Issue: 1
Pages: 3-8
Publication
First Author: Graham EM
Year: 2004
Journal: Neurobiol Dis
Title: Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury.
Volume: 17
Issue: 1
Pages: 89-98
Publication
First Author: Duez C
Year: 2001
Journal: J Allergy Clin Immunol
Title: Fas deficiency delays the resolution of airway hyperresponsiveness after allergen sensitization and challenge.
Volume: 108
Issue: 4
Pages: 547-56
Publication
First Author: Thomas HE
Year: 1999
Journal: J Immunol
Title: Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Volume: 163
Issue: 3
Pages: 1562-9
Publication
First Author: Mountz JD
Year: 1995
Journal: J Immunol
Title: Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock.
Volume: 155
Issue: 10
Pages: 4829-37
Publication
First Author: Komano H
Year: 1999
Journal: Int Immunol
Title: Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells.
Volume: 11
Issue: 7
Pages: 1035-42
Publication
First Author: Papiernik M
Year: 1995
Journal: Eur J Immunol
Title: Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice.
Volume: 25
Issue: 6
Pages: 1517-23
Publication
First Author: Watanabe D
Year: 1995
Journal: EMBO J
Title: Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
Volume: 14
Issue: 1
Pages: 12-8
Publication
First Author: Seino K
Year: 1996
Journal: Int Immunol
Title: Contribution of Fas ligand to cardiac allograft rejection.
Volume: 8
Issue: 9
Pages: 1347-54
Publication      
First Author: Nagata S
Year: 1993
Title: The Fas antigen gene is the structural gene for murine lymphoproliferation mutation (lpr)
Pages: 132-137
Publication
First Author: Singer GG
Year: 1994
Journal: Immunity
Title: The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.
Volume: 1
Issue: 5
Pages: 365-71
Publication
First Author: Weintraub JP
Year: 1998
Journal: Cell Immunol
Title: Immunological and pathological consequences of mutations in both Fas and Fas ligand.
Volume: 186
Issue: 1
Pages: 8-17
Publication
First Author: Satoh M
Year: 2000
Journal: J Immunol
Title: Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Volume: 165
Issue: 2
Pages: 1036-43
Publication
First Author: Yamagiwa S
Year: 1996
Journal: Eur J Immunol
Title: Existence of a small population of IL-2R beta hi TCRint cells in SCG and MRL-lpr/lpr mice which produce normal Fas mRNA and Fas molecules from the lpr gene.
Volume: 26
Issue: 7
Pages: 1409-16
Publication
First Author: Kobayashi S
Year: 1993
Journal: Biochem Biophys Res Commun
Title: Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice.
Volume: 191
Issue: 2
Pages: 617-24
Publication
First Author: Chu JL
Year: 1993
Journal: J Exp Med
Title: The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn.
Volume: 178
Issue: 2
Pages: 723-30
Publication
First Author: Kaplan HJ
Year: 1999
Journal: Nat Med
Title: Fas ligand (CD95 ligand) controls angiogenesis beneath the retina.
Volume: 5
Issue: 3
Pages: 292-7
Publication
First Author: Savinov AY
Year: 2003
Journal: Proc Natl Acad Sci U S A
Title: Contribution of Fas to diabetes development.
Volume: 100
Issue: 2
Pages: 628-32
Publication
First Author: Mao Q
Year: 2008
Journal: Am J Respir Cell Mol Biol
Title: The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.
Volume: 39
Issue: 6
Pages: 717-29
Publication
First Author: Dudani R
Year: 2008
Journal: J Immunol
Title: Mutation in the Fas pathway impairs CD8+ T cell memory.
Volume: 180
Issue: 5
Pages: 2933-41
Publication
First Author: Itoh N
Year: 1997
Journal: J Exp Med
Title: Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.
Volume: 186
Issue: 4
Pages: 613-8
Publication
First Author: Sun M
Year: 2007
Journal: J Immunol
Title: Cutting edge: two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation.
Volume: 179
Issue: 9
Pages: 5639-43
Publication
First Author: Vence L
Year: 2004
Journal: Diabetes
Title: Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells.
Volume: 53
Issue: 11
Pages: 2797-803
Publication
First Author: Mountz JD
Year: 1994
Journal: Int Rev Immunol
Title: Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.
Volume: 11
Issue: 4
Pages: 321-42
Publication
First Author: Smith KG
Year: 1995
Journal: Proc Natl Acad Sci U S A
Title: FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen.
Volume: 92
Issue: 25
Pages: 11628-32
Publication
First Author: Watanabe-Fukunaga R
Year: 1992
Journal: Nature
Title: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
Volume: 356
Issue: 6367
Pages: 314-7
Publication
First Author: Wu J
Year: 1993
Journal: J Exp Med
Title: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene.
Volume: 178
Issue: 2
Pages: 461-8
Publication
First Author: Desbarats J
Year: 2000
Journal: Nat Med
Title: Fas engagement accelerates liver regeneration after partial hepatectomy.
Volume: 6
Issue: 8
Pages: 920-3
Publication
First Author: Nagata S
Year: 1995
Journal: Science
Title: The Fas death factor.
Volume: 267
Issue: 5203
Pages: 1449-56
Publication
First Author: Fecho K
Year: 1998
Journal: Cell Immunol
Title: Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
Volume: 188
Issue: 1
Pages: 19-32
Publication
First Author: Senju S
Year: 1996
Journal: Int Immunol
Title: Functional significance of the Fas molecule in naive lymphocytes.
Volume: 8
Issue: 3
Pages: 423-31
Publication
First Author: Adachi M
Year: 1993
Journal: Proc Natl Acad Sci U S A
Title: Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.
Volume: 90
Issue: 5
Pages: 1756-60
Publication
First Author: Wu J
Year: 1994
Journal: Proc Natl Acad Sci U S A
Title: Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice.
Volume: 91
Issue: 6
Pages: 2344-8
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Publication
First Author: Wueest S
Year: 2010
Journal: FEBS Lett
Title: Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt.
Volume: 584
Issue: 19
Pages: 4187-92
Publication
First Author: Matsuzawa A
Year: 2002
Journal: Immunology
Title: Significant role of Fas ligand-binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double-negative T cells.
Volume: 106
Issue: 4
Pages: 470-5
Publication
First Author: Ols ML
Year: 2016
Journal: Immunity
Title: Dendritic Cells Regulate Extrafollicular Autoreactive B Cells via T Cells Expressing Fas and Fas Ligand.
Volume: 45
Issue: 5
Pages: 1052-1065
Publication
First Author: Kishimoto H
Year: 1998
Journal: J Exp Med
Title: A role for Fas in negative selection of thymocytes in vivo.
Volume: 187
Issue: 9
Pages: 1427-38
Publication
First Author: Liu K
Year: 2003
Journal: J Immunol
Title: Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence.
Volume: 170
Issue: 12
Pages: 5973-80
Publication
First Author: Dowdell KC
Year: 2009
Journal: Exp Hematol
Title: Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).
Volume: 37
Issue: 4
Pages: 487-94
Publication
First Author: Drappa J
Year: 1993
Journal: Proc Natl Acad Sci U S A
Title: The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
Volume: 90
Issue: 21
Pages: 10340-4
Publication
First Author: Lückerath K
Year: 2011
Journal: Blood
Title: Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain.
Volume: 117
Issue: 2
Pages: 519-29
Publication
First Author: Morris JE
Year: 2012
Journal: J Immunol
Title: Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.
Volume: 188
Issue: 2
Pages: 793-9
Publication
First Author: Nguyen QD
Year: 2001
Journal: Invest Ophthalmol Vis Sci
Title: Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
Volume: 42
Issue: 11
Pages: 2505-9
Publication
First Author: Peng SL
Year: 1996
Journal: J Exp Med
Title: A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.
Volume: 184
Issue: 3
Pages: 1149-54
Publication
First Author: Musette P
Year: 1994
Journal: Eur J Immunol
Title: The expansion of a CD4+ T cell population bearing a distinctive beta chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection.
Volume: 24
Issue: 11
Pages: 2761-6
Publication
First Author: Ashany D
Year: 1999
Journal: J Immunol
Title: Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Volume: 163
Issue: 10
Pages: 5303-11
Publication
First Author: Choi EW
Year: 2020
Journal: Sci Rep
Title: Fas mutation reduces obesity by increasing IL-4 and IL-10 expression and promoting white adipose tissue browning.
Volume: 10
Issue: 1
Pages: 12001
Publication
First Author: Izawa T
Year: 2007
Journal: Blood
Title: Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance.
Volume: 110
Issue: 1
Pages: 242-50
Publication
First Author: Zimmermann C
Year: 1996
Journal: Eur J Immunol
Title: Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95).
Volume: 26
Issue: 12
Pages: 2903-10
Publication
First Author: Van Parijs L
Year: 1998
Journal: J Immunol
Title: Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
Volume: 160
Issue: 5
Pages: 2065-71
Publication
First Author: Koulnis M
Year: 2011
Journal: PLoS One
Title: Negative autoregulation by Fas stabilizes adult erythropoiesis and accelerates its stress response.
Volume: 6
Issue: 7
Pages: e21192
Publication
First Author: Cohen PL
Year: 1992
Journal: Immunol Today
Title: The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane.
Volume: 13
Issue: 11
Pages: 427-8
Publication
First Author: Yoshida T
Year: 2000
Journal: Int Immunol
Title: Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
Volume: 12
Issue: 4
Pages: 517-26
Publication
First Author: Kägi D
Year: 1994
Journal: Science
Title: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.
Volume: 265
Issue: 5171
Pages: 528-30
Publication
First Author: Yajima N
Year: 2004
Journal: Int Immunol
Title: Age-related thymic involution is mediated by Fas on thymic epithelial cells.
Volume: 16
Issue: 7
Pages: 1027-35
Publication
First Author: Stuart PM
Year: 2005
Journal: Eur J Immunol
Title: The role of Fas ligand as an effector molecule in corneal graft rejection.
Volume: 35
Issue: 9
Pages: 2591-7
Publication
First Author: Booker JK
Year: 1998
Journal: J Immunol
Title: Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice.
Volume: 161
Issue: 9
Pages: 4536-41
Publication
First Author: Sabelko-Downes KA
Year: 1999
Journal: J Exp Med
Title: Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis.
Volume: 189
Issue: 8
Pages: 1195-205
Publication
First Author: Kim SH
Year: 2007
Journal: J Immunol
Title: MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner.
Volume: 179
Issue: 4
Pages: 2235-41
Publication
First Author: Boone DL
Year: 2003
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Fas is not essential for lamina propria T lymphocyte homeostasis.
Volume: 285
Issue: 2
Pages: G382-8
Publication
First Author: Do Y
Year: 2003
Journal: Int Immunol
Title: Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease.
Volume: 15
Issue: 11
Pages: 1327-40
Publication
First Author: Liu F
Year: 2012
Journal: J Biol Chem
Title: NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression.
Volume: 287
Issue: 30
Pages: 25530-40
Publication
First Author: Ohno T
Year: 2005
Journal: Immunogenetics
Title: Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice.
Volume: 57
Issue: 3-4
Pages: 293-6
Publication
First Author: Kovacic N
Year: 2010
Journal: Lab Invest
Title: Fas receptor is required for estrogen deficiency-induced bone loss in mice.
Volume: 90
Issue: 3
Pages: 402-13
Publication
First Author: Nagata S
Year: 1995
Journal: Immunol Today
Title: Fas and Fas ligand: lpr and gld mutations.
Volume: 16
Issue: 1
Pages: 39-43
Publication
First Author: Brown NJ
Year: 2004
Journal: J Immunol
Title: Fas death receptor signaling represses monocyte numbers and macrophage activation in vivo.
Volume: 173
Issue: 12
Pages: 7584-93
Publication
First Author: O'Donnell JA
Year: 2015
Journal: J Leukoc Biol
Title: Fas regulates neutrophil lifespan during viral and bacterial infection.
Volume: 97
Issue: 2
Pages: 321-6
Publication
First Author: Adachi M
Year: 1995
Journal: Nat Genet
Title: Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver.
Volume: 11
Issue: 3
Pages: 294-300
Publication
First Author: Wueest S
Year: 2014
Journal: EMBO Mol Med
Title: Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance.
Volume: 6
Issue: 1
Pages: 43-56
Publication
First Author: Landau AM
Year: 2005
Journal: J Exp Med
Title: Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease.
Volume: 202
Issue: 5
Pages: 575-81
Publication
First Author: Conceição-Silva F
Year: 1998
Journal: Eur J Immunol
Title: The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity.
Volume: 28
Issue: 1
Pages: 237-45
GXD Expression      
Probe: MGI:6172684
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689419
Stage: TS19
Assay Id: MGI:6190249
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Fas
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:6172684
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689421
Stage: TS21
Assay Id: MGI:6190249
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Fas
Detected: false
Specimen Num: 2
GXD Expression      
Probe: MGI:6172684
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689424
Stage: TS24
Assay Id: MGI:6190249
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Fas
Detected: false
Specimen Num: 3
GXD Expression      
Probe: MGI:6172684
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689426
Stage: TS26
Assay Id: MGI:6190249
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Fas
Detected: false
Specimen Num: 4